Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Enzo v. Applera et al.

This article was originally published in The Gray Sheet

Executive Summary

DNA sequencing technologies and diagnostics firm Enzo Biochem appeals Connecticut federal court's grant of summary judgment in favor of Applera in a patent infringement suit, which dismissed all claims against Applera. Enzo is suing Applera for alleged past infringement of three now-expired patents related to nucleic acid labeling and detection based on the work of Dr. David C. Ward at Yale University. The court ruled that the three patents were invalid because they "fail to provide the public with adequate guidance of what is and what is not covered," and were not novel "because prior scientific publications described the same subject matter." Enzo notes that the ruling relates solely to the three expired patents and is unrelated to its ongoing business or other litigation
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT025252

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel